| Literature DB >> 28666867 |
Kazumasa Kuki1, Noritaka Yamaguchi2, Shuto Iwasawa1, Yuki Takakura1, Kazumasa Aoyama1, Ryuzaburo Yuki1, Yuji Nakayama3, Takahisa Kuga3, Yuuki Hashimoto4, Takeshi Tomonaga4, Naoto Yamaguchi5.
Abstract
c-Abl is a non-receptor-type tyrosine kinase that plays an important role in cell proliferation, migration, apoptosis, and fibrosis. Furthermore, although c-Abl is involved in transforming growth factor-β (TGF-β) signaling, its molecular functions in TGF-β signaling are not fully understood. Here, we found that c-Abl phosphorylates SKI-interacting protein (SKIP), a nuclear cofactor of the transcription factor Smad3. The c-Abl inhibitor imatinib suppressed TGF-β-induced expression of Smad3 targets as well as SKIP/Smad3 interaction. TGF-β-stimulation induced tyrosine phosphorylation of SKIP, and this phosphorylation was suppressed by imatinib. Tyr292, Tyr430, and Tyr433 residues in SKIP were shown to be involved in c-Abl-mediated phosphorylation. Phosphomimetic glutamic acid substitution at Tyr292 in SKIP enhanced, whereas its phospho-dead phenylalanine substitution attenuated TGF-β-induced SKIP/Smad3 interaction. Moreover, the phosphomimetic mutant of SKIP augmented transcriptional activity of Smad3. Taken together, these results suggest that c-Abl phosphorylates SKIP mainly at Tyr292 and promotes SKIP/Smad3 interaction for the full activation of TGF-β/Smad3 signaling.Entities:
Keywords: Nuclear cofactor; SKI-interacting protein (SKIP, SNW1, NCoA62); Smad3; Transforming growth factor-β (TGF-β); c-Abl
Mesh:
Substances:
Year: 2017 PMID: 28666867 DOI: 10.1016/j.bbrc.2017.06.163
Source DB: PubMed Journal: Biochem Biophys Res Commun ISSN: 0006-291X Impact factor: 3.575